Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

CNY 7.57

(0.53%)

Gross Profit Summary of Sichuan Goldstone Asia Pharmaceutical Inc.

  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest annual gross profit in 2023 was 742.28 Million CNY , down -2.6% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest quarterly gross profit in 2024 Q3 was 122.27 Million CNY , up 63.45% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a annual gross profit of 762.1 Million CNY in annual gross profit 2022, up 27.49% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a annual gross profit of 597.78 Million CNY in annual gross profit 2021, up 42.71% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a quarterly gross profit of 216.66 Million CNY for 2024 Q1, down -11.41% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a quarterly gross profit of 74.81 Million CNY for 2024 Q2, down -65.47% from previous quarter.

Annual Gross Profit Chart of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Historical Annual Gross Profit of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 742.28 Million CNY -2.6%
2022 762.1 Million CNY 27.49%
2021 597.78 Million CNY 42.71%
2020 418.88 Million CNY -35.37%
2019 648.16 Million CNY 1.28%
2018 640 Million CNY 42.04%
2017 450.59 Million CNY 701.16%
2016 56.24 Million CNY 22.09%
2015 46.06 Million CNY -32.51%
2014 68.25 Million CNY -23.16%
2013 88.83 Million CNY -15.14%
2012 104.68 Million CNY 8.45%
2011 96.52 Million CNY 0.0%

Peer Gross Profit Comparison of Sichuan Goldstone Asia Pharmaceutical Inc.

Name Gross Profit Gross Profit Difference
China National Complete Plant Import & Export Corporation Limited -188.98 Million CNY 492.771%